This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
As new companies enter the market for finished paclitaxel, bulk demand will increase as competition forces down prices, the study notes, adding that, with the drug becoming more affordable, physicians are expected to prescribe it more freely. However, while demand may be rising, paclitaxel is derived from a natural resource, and its long-term availability is in question.
Yew trees are slow-growing, and the extraction process requires numerous trees to supply an adequate amount, it says. The possible scarcity of the product is spurring sales, especially to the research sector where large stocks are necessary for proper experimentation. However, the report notes that enterprising companies have found ways to circumvent this issue and increase supply.
With advances in technology, new and better ways of extracting paclitaxel have evolved, with plant cell culture techniques and genetic engineering also emerging as fruitful methods of enhancing production says F&S. These methods have resulted in ample and continuous supplies, which is expected to boost the quantities of bulk paclitaxel, and subsequently augment the revenues generated by finished products, the report adds.
Global 10-Deacetylbaccatin III market size will increase to 78 Million US$ by 2025, from 58 Million US$ in 2018, at a CAGR of 3.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for 10-Deacetylbaccatin III.
This report researches the worldwide 10-Deacetylbaccatin III market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global 10-Deacetylbaccatin III breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Sarv Biolabs Pvt
Hainan Yew Pharmaceutical
10-Deacetylbaccatin III Breakdown Data by Type
10-Deacetylbaccatin III Breakdown Data by Application
Production of Docetaxel
Production of Paclitaxel
10-Deacetylbaccatin III Production Breakdown Data by Region
10-Deacetylbaccatin III Consumption Breakdown Data by Region
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global 10-Deacetylbaccatin III capacity, production, value, consumption, status and forecast;
To focus on the key 10-Deacetylbaccatin III manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of 10-Deacetylbaccatin III :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.